Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2, replacing the prior v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T01:50:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-05T00:35:38.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A glossary feature was added to the page, and there are minor text/capitalization changes plus a new version label (Revision: v3.4.0). The core study content and user actions remain unchanged.
    Difference
    0.2%
    Check dated 2026-01-28T21:44:57.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:09:06.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations section reorganized under a single Locations heading listing Florida and North Carolina; the HHS Vulnerability Disclosure link was removed and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:12:40.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no study content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:55:49.000Z thumbnail image

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.